Sensor Improves Glucose Control in Type 1 Diabetes
Mary Tyler Moore—beloved actress, comedian, and passionate spokesman for diabetes research—passed away on January 25th. Moore's lifelong struggle with type 1 diabetes was well known and she is credited with proving it's possible to live well with diabetes. According to two new studies published in JAMA, an implantable sensor that continuously monitors blood glucose levels in people with type 1 diabetes results in improved glucose levels compared to conventional diabetes treatment. Continuous glucose monitoring (CGM) systems are used by just a small percentage of people with type 1 diabetes who take insulin several times a day.
It's estimated that only 30 percent of people with type 1 diabetes meet goals set by the American Diabetes Association of HbA1c level of 7.5 percent for children and 7.0 percent for adults—indicating a better approach to diabetes management is needed. Continuous glucose monitoring, which measures glucose as often as every five minutes and provides low and high glucose level alerts as well as glucose trend information, may be the answer.
Both studies showed improved glucose control in people using CGM. More research is needed to study the long-term effectiveness of continuous glucose monitoring to manage type 1 diabetes. Diagnosed with type 1 diabetes at the age of 33, it's not known at this time if the disease contributed to Mary Tyler Moore's death at the age of 80.
Image Credit: Thinkstock